{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:38:25Z","timestamp":1772134705442,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10072-011-0672-7","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T22:11:11Z","timestamp":1309212671000},"page":"261-267","source":"Crossref","is-referenced-by-count":26,"title":["Retrospective evaluation of the dose equivalence of Botox\u00ae and Dysport\u00ae in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story"],"prefix":"10.1007","volume":"33","author":[{"given":"Anna Rita","family":"Bentivoglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e0mara","family":"Ialongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"De Nigris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"issue":"Suppl 1","key":"672_CR1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/j.1468-1331.2006.01439.x","volume":"13","author":"D Dressler","year":"2006","unstructured":"Dressler D, Hallet M (2006) Immunological aspects of Botox, Dysport and Myobloc\/Neurobloc. Eur J Neurol 13(Suppl 1):S11\u2013S15","journal-title":"Eur J Neurol"},{"issue":"Suppl. 8","key":"672_CR2","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/mds.20066","volume":"19","author":"C Sampaio","year":"2004","unstructured":"Sampaio C, Costa J, Ferreira JJ (2004) Clinical comparability of marketed formulations of botulinum toxin. Mov Disord 19(Suppl. 8):S129\u2013S136","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"672_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00007813","volume":"248","author":"WH Jost","year":"2001","unstructured":"Jost WH, Kohl A (2001) Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 248(Suppl 1):21\u201324","journal-title":"J Neurol"},{"key":"672_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1468-1331.2006.01537.x","volume":"13","author":"A Albanese","year":"2006","unstructured":"Albanese A, Barnes MP, Bhatia KP, Fernandez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Sol\u00e8 J (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes. Report by an EFNS\/MDS-ES Task Force. Eur J Neurol 13:433\u2013444","journal-title":"Eur J Neurol"},{"key":"672_CR5","first-page":"151","volume":"49","author":"K Digre","year":"1988","unstructured":"Digre K, Corbett JJ (1988) Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 49:151\u2013176","journal-title":"Adv Neurol"},{"key":"672_CR6","first-page":"371","volume":"16","author":"J Jankovic","year":"1984","unstructured":"Jankovic J, Orman J (1984) Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 16:371\u2013376","journal-title":"Ann Ophthalmol"},{"key":"672_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","volume":"35","author":"RE Burke","year":"1985","unstructured":"Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73\u201377","journal-title":"Neurology"},{"issue":"Suppl 4","key":"672_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1468-1331.2006.01649.x","volume":"13","author":"KR Aoki","year":"2006","unstructured":"Aoki KR, Ranoux D, Wissel J (2006) Using translational medicine to understand clinical differences between botulinum toxin formulations. Eur J Neurol 13(Suppl 4):10\u201319","journal-title":"Eur J Neurol"},{"key":"672_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","volume":"355","author":"K Wohlfarth","year":"1997","unstructured":"Wohlfarth K, Goschel H, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol 355:335\u2013340","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"672_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mds.20468","volume":"20","author":"A Marchetti","year":"2005","unstructured":"Marchetti A, Magar R, Findley L, Larsen JP, Pirtosek Z, R\u016fzicka E, Jech R, S\u0142awek J, Ahmed F (2005) Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study. Mov Disord 20:937\u2013944","journal-title":"Mov Disord"},{"key":"672_CR11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"C Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Sim\u00f5es F, Rosas MJ, Magalh\u00e3es M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox\u2014assuming a ratio of 4:1. Mov Disord 12:1013\u20131018","journal-title":"Mov Disord"},{"key":"672_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","volume":"235","author":"Z Nussgens","year":"1997","unstructured":"Nussgens Z, Roggenkamper P (1997) Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 235:197\u2013199","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"672_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","volume":"64","author":"T Odergren","year":"1998","unstructured":"Odergren T, Hjaltason H, Kaakkola S, Solders G, Hanko J, Fehling C, Marttila RJ, Lundh H, Gedin S, Westergren I, Richardson A, Dott C, Cohen H (1998) A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64:6\u201312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"672_CR14","first-page":"459","volume":"72","author":"D Ranoux","year":"2002","unstructured":"Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72:459\u2013462","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"672_CR15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.73.5.604","volume":"73","author":"D Dressler","year":"2002","unstructured":"Dressler D (2002) Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia. J Neurol Neurosurg Psychiatry 73:604","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"672_CR16","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/mds.20012","volume":"19 Suppl 8","author":"K Wohlfarth","year":"2004","unstructured":"Wohlfarth K, Kampe K, Bigalke H (2004) Pharmacokinetic properties of different formulations of botulinum neurotoxin type A. Mov Disord 19 Suppl 8:S65\u2013S67","journal-title":"Mov Disord"},{"key":"672_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0041-0101(96)00070-0","volume":"34","author":"K Mclellan","year":"1996","unstructured":"Mclellan K, Das RE, Ekong TA, Sesardic D (1996) Therapeutic botulinum type A toxin: factors affecting potency. Toxicon 34:975\u2013985","journal-title":"Toxicon"},{"key":"672_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079905X36396","volume":"21","author":"K Binari","year":"2005","unstructured":"Binari K (2005) Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm. Curr Med Res Opin 21:433\u2013438","journal-title":"Curr Med Res Opin"},{"key":"672_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/NRL.0b013e31816f2cdd","volume":"14","author":"A Brashear","year":"2008","unstructured":"Brashear A (2008) Clinical comparisons of botulinum neurotoxin formulations. Neurol 14:289\u2013298","journal-title":"Neurol"},{"key":"672_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2710.2007.00835.x","volume":"32","author":"R Wenzel","year":"2007","unstructured":"Wenzel R, Jones D, Borrego JA (2007) Comparing two botulinum toxin type A formulations using manufacturers product. J Clin Pharm Ther 32:387\u2013402","journal-title":"J Clin Pharm Ther"},{"key":"672_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp.59.1.102","volume":"59","author":"MH Marion","year":"1995","unstructured":"Marion MH, Sheehy M, Sangla S, Soulayrol S (1995) Dose standardisation of botulinum toxin. J Neurol Neurosurg Psychiatry 59:102\u2013103","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"672_CR22","first-page":"17","volume":"2","author":"D Durif","year":"1995","unstructured":"Durif D (1995) Clinical bioequivalence of the current commercial preparations of botulinum toxin. Eur J Neurol 2:17\u201318","journal-title":"Eur J Neurol"},{"key":"672_CR23","first-page":"231","volume":"78","author":"PY Bergh Van den","year":"1998","unstructured":"Van den Bergh PY, Lison DF (1998) Dose standardization of botulinum toxin. Adv Neurol 78:231\u2013235","journal-title":"Adv Neurol"},{"key":"672_CR24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1046\/j.1365-2036.1999.00602.x","volume":"13","author":"V Annese","year":"1999","unstructured":"Annese V, Bassotti G, Coccia G, D\u2019Onofrio V, Gatto G, Repici A, Andriulli A (1999) Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia The Gismad Achalasia Study Group. Aliment Pharmacol Ther 13:1347\u20131350","journal-title":"Aliment Pharmacol Ther"},{"key":"672_CR25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","volume":"149","author":"M Simonetta Moreau","year":"2003","unstructured":"Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM (2003) A double-blind, randomized, comparative study of Dysport versus Botox in primary palmar hyperhidrosis. Br J Dermatol 149:1041\u20131045","journal-title":"Br J Dermatol"},{"key":"672_CR26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2004.01895.x","volume":"19","author":"G Brisinda","year":"2004","unstructured":"Brisinda G, Albanese A, Cadeddu F, Bentivoglio AR, Mabisombi A, Marniga G, Maria G (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized \u201cBotox vs. Dysport\u201d controlled trial. Aliment Pharmacol Ther 19:695\u2013701","journal-title":"Aliment Pharmacol Ther"},{"key":"672_CR27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.143.11.1447-b","volume":"143","author":"S Karsai","year":"2007","unstructured":"Karsai S, Adrian R, Hammes S, Thimm J, Raulin C (2007) A randomized double-blind study of the effect of Botox and Dysport\/Reloxin on forehead wrinkles and electromyographic activity. Arch Dermatol 143:1447\u20131449","journal-title":"Arch Dermatol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0672-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-011-0672-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0672-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:19:33Z","timestamp":1559107173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-011-0672-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s10072-011-0672-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}